InterVenn Biosciences Inc.
Overview
InterVenn Biosciences is a biotechnology company that leverages its proprietary glycoproteomics technology to transform the diagnosis and treatment of cancer and other diseases. The company provides novel insights into the biology of glycosylation, offering breakthroughs in predictive, non-invasive tests and therapies.
Therapeutic areas
OncologyDiagnostics
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to InterVenn Biosciences Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Becton, Dickinson and Company
United States
ColoSTAT Biotech Inc.
United States
Freenome Holdings, Inc.
United States
OPKO Health, Inc.
United States
Pharmalucence Inc.
United States
Ventana Medical Systems, Inc.
United States
Rhythm Biosciences Limited
Australia
3D Imaging Drug Design and Development LLC
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.